Abstract
Infective endocarditis is still a life-threatening event that may significantly impair long-term prognosis of patients with cardiac disease. The profile of infective endocarditis has changed over the past two decades with decreasing cases in rheumatic cardiac disease and increasing cases in patients who survive with congenital heart disease. Given high rates of morbidity and mortality of infective endocarditis episodes, antibiotic prophylaxis has long been recommended for high-risk groups. Guidelines have serially changed over years. The most recent revised recommendations significantly differ from previous guidelines and give new insights into the prophylaxis of infective endocarditis. Emphasis has shifted to oral activities and particularly on teeth brushing. Both buccal and skin hygiene may present the greatest threats for individuals at risk of infective endocarditis. Significant limitations in both at-risk patients and procedures result in a potential and substantial change in clinical practice and raise concerns about the safety and reliability of these new recommendations for patients with congenital heart disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wilson W, Taubert KA, Gewitz M et al (2007) Endocarditis guidelines from the American Heart Association a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation 116:1736–1754
Pharis CS, Conway J, Warren AE et al (2011) The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists. Am Heart J 161:123–129
Baumgartner H, Bonhoeffer P, De Groot NMS et al (2010) The task force on the management of grown-up congenital heart disease of the European Society of Cardiology (ESC), endorsed by the Association for European Paediatric Cardiology (AEPC). Eur Heart J 31:2915–2957
Di Filippo S, Delahaye F, Semiond B et al (2006) Current patterns of infective endocarditis in congenital heart disease. Heart 92:1490–1495
Rostagno C, Rosso G, Puggelli F et al (2010) Active infective endocarditis: clinical characteristics and factors related to hospital mortality. Cardiol J 17:566–573
Rosenthal LB, Feja KN, Levasseur SM et al (2010) The changing epidemiology of pediatric endocarditis at a children’s hospital over seven decades. Pediatr Cardiol 31:813–820
Siddiqui BK, Tariq M, Jadoon A et al (2007) Infective endocarditis in patients with congenitally malformed hearts: characterization of the syndrome in a developing country. Cardiol Young 17:623–630
Day MD, Gauvreau K, Shulman S et al (2009) Characteristics of children hospitalized with infective endocarditis. Circulation 119:865–870
Yoshinaga M, Niwa K, Niwa A et al (2008) Joint working groups for guidelines for prophylaxis, diagnosis and management of infective endocarditis in patients with congenital heart disease. Risk factors for in-hospital mortality during infective endocarditis in patients with congenital heart disease. Am J Cardiol 101:114–118
Knirsch W, Nadal D (2011) Infective endocarditis in congenital heart disease. Eur J Pediatr 170:1111–1127
Tansel T, Onursal E, Eker R et al (2005) Results of surgical treatment for infective endocarditis in children. Cardiol Young 15:621–626
Lockhart PB, Brennan MT, Kent ML et al (2004) Impact of amoxicillin prophylaxis on the incidence, nature and duration of bacteremia in children after intubation and dental procedures. Circulation 109:2878–2884
Glauser MP, Bernard JP, Moreillon P et al (1983) Successful single-dose amoxicillin prophylaxis against experimental streptococcal endocarditis: evidence for two mechanisms of protection. J Infect Dis 147:568–575
Duval X, Alla F, Hoen B et al (2006) Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 42:e102–e107
Que Y, Moreillon P (2011) Infective endocarditis. Nat Rev Cardiol 8:322–336
Moreillon P, Dargère S, Piroth L et al (2002) Infective endocarditis prophylaxis: lessons from the experimental model. Med Mal Infect 32:605–612
Durack DT (1995) Prevention of infective endocarditis. N Engl J Med 332:38–44
Delahaye F, Harbaoui B, Cart-Regal V et al (2009) Dramatic changes over the past seven years. Arch Cardiovasc Dis 102:233–245
Valle-Caballero MJ, Muñoz-Caleroa B, Arajib OA (2010) Current indications for infective endocarditis antibiotic prophylaxis. Infect Disord Drug Targets 10:59–64
Morris CD, Reller MD, Menashe VD (1998) Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA 279:599–603
Horder TJ (1909) Infective endocarditis with analysis of 150 cases and with special reference to the chronic form of the disease. Q J Med 2:289–324
Imperiale TF, Horwitz RI (1990) Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 88:131–136
Oliver R, Roberts GJ, Hooper L, Worthington HV (2008). Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database of Systematic Reviews Issue 4. Art. No.: CD003813.
Kluger N (2009) Bacterial endocarditis and body art: suggestions for an active prevention. Int J Cardiol 136:112–113
Lockhart PB, Brennan MT, Kent ML et al (2008) Bacteremia associated with tooth brushing and dental extraction. Circulation 117:3118–3125
Penny DJ, Vick GW (2011) Ventricular septal defect. Lancet 377:1103–1112
Gersony WM, Hayes CJ, Driscoll DJ et al (1993) Bacterial endocarditis in patients with aortic-stenosis, pulmonary stenosis, or ventricular septal-defect. Circulation 87:121–126
Siu SC, Silversides CK (2010) Bicuspid aortic valve disease. J Am Coll Cardiol 55:2789–2800
Giroud JM, Jacobs JP (2007) Evolution of strategies for management of the patent arterial duct. Cardiol Young 17:68–74
Hayek E, Gring CN, Griffin BP (2005) Mitral valve prolapse. Lancet 365:507–518
Zuppiroli A, Rinaldi M, Kramer-Fox R et al (1995) Natural history of mitral valve prolapse. Am J Cardiol 75:1028–1032
Cheitlin MD, Armstrong WF, Aurigemma GP et al (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 42:954–970
Shebani SO, Miles HF, Simmons P et al (2007) Awareness of the risk of endocarditis associated with tattooing and body piercing among patients with congenital heart disease and paediatric cardiologists in the United Kingdom. Arch Dis Child 92:1013–1014
Dhoble A, Vedre A, Abdelmoneim SS et al (2009) Prophylaxis to prevent infective endocarditis: to use or not to use? Clin Cardiol 32:429–433
Weaver WD, Nishimura RA, Warnes CA (2008) President’s page: antimicrobial prophylaxis to prevent infective endocarditis: why did the recommendations change? J Am Coll Cardiol 52:495–497
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this entry
Cite this entry
Filippo, S.D. (2014). Prevention of Infective Endocarditis in Patients with Congenital Heart Disease. In: Da Cruz, E., Ivy, D., Jaggers, J. (eds) Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer, London. https://doi.org/10.1007/978-1-4471-4619-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4619-3_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4618-6
Online ISBN: 978-1-4471-4619-3
eBook Packages: MedicineReference Module Medicine